Liu Z, Cai L, Xing M, Qiao N, Liu J, Li X
Biosaf Health. 2025; 6(3):153-164.
PMID: 40078728
PMC: 11894967.
DOI: 10.1016/j.bsheal.2024.04.001.
Welsh S, Zhang Y, Smith R
Clin Kidney J. 2025; 18(3):sfaf022.
PMID: 40052168
PMC: 11883229.
DOI: 10.1093/ckj/sfaf022.
Quang C, Anderson J, Russell F, Reyburn R, Ratu T, Tuivaga E
Nat Commun. 2025; 16(1):2130.
PMID: 40032823
PMC: 11876628.
DOI: 10.1038/s41467-025-57443-z.
Aurelia L, Purcell R, Theisen R, Kelly A, Esterbauer R, Ramanathan P
Sci Adv. 2025; 11(9):eads1482.
PMID: 40009690
PMC: 11864192.
DOI: 10.1126/sciadv.ads1482.
Juarez I, Perez-Flores I, Aiffil Meneses A, Lopez-Gomez A, Calvo Romero N, Rodriguez-Cubillo B
Vaccines (Basel). 2025; 13(2).
PMID: 40006670
PMC: 11860609.
DOI: 10.3390/vaccines13020123.
Diverse Roles of Antibodies in Antibody-Drug Conjugates.
Yamaguchi A, Manning H
Pharmaceuticals (Basel). 2025; 18(2).
PMID: 40005994
PMC: 11859538.
DOI: 10.3390/ph18020180.
Characterization of Anti-Insulin Antibodies in Type 1 and Type 2 Diabetes Mellitus: Clinical Relevance.
Toft-Hansen H, Aniol-Nielsen C, Elias D, Dahlback M, Rossing P, Sivalingam S
Int J Mol Sci. 2025; 26(4).
PMID: 40004193
PMC: 11854962.
DOI: 10.3390/ijms26041730.
The human immunoglobulin heavy chain constant gene locus is enriched for large complex structural variants and coding polymorphisms that vary in frequency among human populations.
Jana U, Rodriguez O, Lees W, Engelbrecht E, Vanwinkle Z, Vanwinkle Z
bioRxiv. 2025; .
PMID: 39990387
PMC: 11844466.
DOI: 10.1101/2025.02.12.634878.
Quantifying antibody binding: techniques and therapeutic implications.
Lodge J, Kajtar L, Duxbury R, Hall D, Burley G, Cordy J
MAbs. 2025; 17(1):2459795.
PMID: 39957177
PMC: 11834528.
DOI: 10.1080/19420862.2025.2459795.
Nipocalimab, an immunoselective FcRn blocker that lowers IgG and has unique molecular properties.
Seth N, Xu R, DuPrie M, Choudhury A, Sihapong S, Tyler S
MAbs. 2025; 17(1):2461191.
PMID: 39936406
PMC: 11834464.
DOI: 10.1080/19420862.2025.2461191.
Immunogenicity of culture filtrated proteins and whole-cell killed formalin of to induced cellular immune response .
Al-Bayati H, Abdullah S, Shihab T, Sultan M, Jumaa Q
Open Vet J. 2025; 14(12):3581-3598.
PMID: 39927340
PMC: 11799627.
DOI: 10.5455/OVJ.2024.v14.i12.40.
Comprehensive proteolytic profiling of Aedes aegypti mosquito midgut extracts: Unraveling the blood meal protein digestion system.
ODonoghue A, Lui C, Liu C, Simington C, Montermoso S, Moreno-Galvez E
PLoS Negl Trop Dis. 2025; 19(2):e0012555.
PMID: 39913535
PMC: 11838913.
DOI: 10.1371/journal.pntd.0012555.
Immunological composition of human milk before and during subclinical and clinical mastitis.
Castro-Navarro I, Pace R, Williams J, Pace C, Kaur H, Piaskowski J
Front Immunol. 2025; 15:1532432.
PMID: 39896819
PMC: 11782115.
DOI: 10.3389/fimmu.2024.1532432.
The Glycosylation of Serum IgG Antibodies in Post-COVID-19 and Post-Vaccination Patients.
Varadi C
Int J Mol Sci. 2025; 26(2.
PMID: 39859521
PMC: 11765615.
DOI: 10.3390/ijms26020807.
Developing a Label-Free Infrared Spectroscopic Analysis with Chemometrics and Computational Enhancement for Assessing Lupus Nephritis Activity.
Yu M, Huang X, Kuo C, Zhang K, Liang P, Jeng U
Biosensors (Basel). 2025; 15(1).
PMID: 39852090
PMC: 11763532.
DOI: 10.3390/bios15010039.
Passive infusion of an S2-Stem broadly neutralizing antibody protects against SARS-CoV-2 infection and lower airway inflammation in rhesus macaques.
Edwards C, Karunakaran K, Garcia E, Beutler N, Gagne M, Golden N
PLoS Pathog. 2025; 21(1):e1012456.
PMID: 39847599
PMC: 11793774.
DOI: 10.1371/journal.ppat.1012456.
How Broadly Neutralising Antibodies Are Redefining Immunity to Influenza.
Steventon R, Stolle L, Thompson C
Antibodies (Basel). 2025; 14(1.
PMID: 39846612
PMC: 11755579.
DOI: 10.3390/antib14010004.
Application of efgartigimod in Chinese patients with myasthenia gravis: a single-center real-world prospective study.
Zhu G, Zhou H, Wang W, Ma Y, Nie X, Qi W
Ther Adv Neurol Disord. 2025; 18():17562864241311127.
PMID: 39839222
PMC: 11748066.
DOI: 10.1177/17562864241311127.
Systematic evaluation of intratumoral and peripheral BCR repertoires in three cancers.
Krasik S, Bryushkova E, Sharonov G, Myalik D, Shurganova E, Komarov D
Elife. 2025; 13.
PMID: 39831798
PMC: 11745494.
DOI: 10.7554/eLife.89506.
Safety, efficacy, and immunogenicity of a novel IgG degrading enzyme (KJ103): results from two randomised, blinded, phase 1 clinical trials.
Cao M, Katial R, Liu Y, Lu X, Gu Q, Chen C
Gene Ther. 2025; .
PMID: 39825100
DOI: 10.1038/s41434-025-00512-1.